PR-5V10 (ras-12 Val) Peptide
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2794
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to valine). Vaccines using mutant ras peptides may be used in the immunotherapy of various cancers that express ras mutations. (NCI04) [ ]
Term info
Label
PR-5V10 (ras-12 Val) Peptide
Synonyms
- PR-5V10 (ras-12 Val) Peptide
- Ras Peptide PR5V10 (KLVVVGAVGV)
Legacy Concept Name
PR5V10_ras-12_Val_Peptide
NSC Code
706862
Preferred Name
PR-5V10 (ras-12 Val) Peptide
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C1518810
code
C2794
Term relations
Subclass of:
- Mutated Ras Peptide
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation